Key stats
About ISHARES TRUST U.S. PHARMACEUTICALS ETF
Home page
Inception date
May 1, 2006
Structure
Open-Ended Fund
Distributes
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Tax on distributions
Qualified dividends
IHE tracks a broad index of US pharmaceutical companies. The fund provides exposure to the manufacturers of prescription or over-the-counter drugs, such as aspirin, cold remedies and birth control pills. The index also includes vaccine producers. IHE may also include companies of all sizes, ranging from large- to small-cap. The index weights its constituents by market cap, with a cap of up to 22.5% per individual company and is rebalanced quarterly. IHE uses a sampling strategy that involves investing in a representative sample of securities that collectively has an investment profile similar to that of an applicable underlying index. Index components are selected on an annual basis.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.86%
Health Technology99.86%
Bonds, Cash & Other0.14%
Mutual fund0.13%
Cash0.01%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history